Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.21 USD | +1.84% | +1.38% | -4.33% |
05-15 | Compugen Names David Silberman CFO | MT |
05-13 | Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.33% | 89.79M | |
+55.70% | 59.34B | |
+42.95% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Transcript : Oramed Pharmaceuticals Inc. Presents at Barclays Global Healthcare Conference 2022, Mar-15-2022 03